Statins and carotid intima-media thickness reduction: an up-to-date review

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Medical Imaging

Background:

• Carotid artery intima-media thickness (CIMT) measured by ultrasound is a validated surrogate marker for atherosclerotic disease and cardiovascular disease.
• Hypercholesterolemia-induced organ damage, particularly atherosclerosis, is a significant concern.
• Statins are known to mitigate cardiovascular risk by improving endothelial function, reducing inflammation, and slowing atherosclerotic progression.

Purpose of the Study:

• To review the effectiveness of various statins in regressing carotid artery intima-media thickness.
• To explore the potential of statins as a therapeutic target for early atherosclerotic processes.
• To highlight the need for further research into the acute anti-inflammatory effects of statins on CIMT.

Main Methods:

• Review of existing literature on statin therapy and carotid intima-media thickness measurements.
• Analysis of studies focusing on lipid-lowering drugs and their impact on atherosclerotic markers.
• Examination of ultrasound-based measurements of CIMT in the context of cardiovascular risk.

Main Results:

• Statins demonstrate a significant role in slowing or arresting the atherosclerotic process.
• CIMT regression is a key indicator of statin efficacy in managing hypercholesterolemia-related vascular damage.
• Further investigation into the anti-inflammatory mechanisms of statins is warranted.

Conclusions:

• Statins are effective in reducing carotid intima-media thickness, indicating a reversal of early atherosclerotic changes.
• Targeting CIMT with lipid-lowering drugs like statins is a crucial strategy in cardiovascular disease prevention.
• Future research should focus on large-scale trials to confirm clinical implications and explore novel therapeutic pathways.